Cargando…

Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma

Radioresistance is a major cause leads to treatment failure in nasopharyngeal carcinoma (NPC). In our previous study, we identified that QSOX1 is a differentially expressed protein in NPC cell lines with variable radiosensitivities. The present study aimed to investigate the biological behavior of Q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lei, Chen, Hong-Min, Qu, Song, Li, Ling, Zhao, Wei, Liang, Zhong-Guo, Yu, Bin-Bin, Chen, Kai-Hua, Lu, Qi-Teng, Lin, Guo-Xiang, Zhu, Xiao-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790459/ https://www.ncbi.nlm.nih.gov/pubmed/29423042 http://dx.doi.org/10.18632/oncotarget.23227

Ejemplares similares

Cancer stem cell‐like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE‐2R
por: Chen, Kai‐Hua, et al.
Publicado: (2018)

The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R
por: Liang, Zhong-Guo, et al.
Publicado: (2018)

Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity
por: Yuan, Li, et al.
Publicado: (2016)

Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma
por: Yu, Bin-Bin, et al.
Publicado: (2018)

Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells
por: Ma, Fei, et al.
Publicado: (2020)

Twist1 promotes radioresistance in nasopharyngeal carcinoma
por: Zhang, Linli, et al.
Publicado: (2016)

Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R
por: Chen, Kaihua, et al.
Publicado: (2020)

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma
por: Qu, Chen, et al.
Publicado: (2017)

Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
por: Zhan, Yuting, et al.
Publicado: (2020)

Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma
por: Wan, Fang-Zhu, et al.
Publicado: (2020)

Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma
por: Guo, Ya, et al.
Publicado: (2019)

BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression
por: Wei, Fang, et al.
Publicado: (2018)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Inhibition of STAT1 sensitizes radioresistant nasopharyngeal carcinoma cell line CNE-2R to radiotherapy
por: Qu, Song, et al.
Publicado: (2017)

Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma
por: Liao, Li, et al.
Publicado: (2018)

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma
por: Liang, Zhong-Guo, et al.
Publicado: (2017)

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy
por: Wang, Cong, et al.
Publicado: (2020)

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R
por: Lin, Guoxiang, et al.
Publicado: (2018)

Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2019)

Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
por: Xiao, Jiaxin, et al.
Publicado: (2021)

QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells
por: Poillet, Laura, et al.
Publicado: (2014)

Immunohistochemical expression of sulfhydryl oxidase (QSOX1) in pediatric medulloblastomas
por: Sobral, Ana Cristina Lira, et al.
Publicado: (2015)

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
por: Chen, Wei, et al.
Publicado: (2015)

Effect of Shengmai Yin on Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Radioresistant Cells
por: Wang, Ze-tai, et al.
Publicado: (2022)

Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Liang, Zhong-Guo, et al.
Publicado: (2016)

SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
por: Nie, Xin, et al.
Publicado: (2019)

High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients
por: Pernodet, Nicolas, et al.
Publicado: (2012)

Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy and intensity-modulated radiotherapy alone for stage II nasopharyngeal carcinoma
por: Chen, Kai-Hua, et al.
Publicado: (2016)

Expression Level of Quiescin Sulfhydryl Oxidase 1 (Qsox1) in Neuroblastomas
por: Araújo, D.G.B., et al.
Publicado: (2014)

Illuminating luminal B: QSOX1 as a subtype-specific biomarker
por: Das, Padmalaya, et al.
Publicado: (2013)

miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP
por: Huang, Wei, et al.
Publicado: (2019)

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021)

Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma
por: Huang, Shi-Ting, et al.
Publicado: (2021)

A Nomogram to Identify the Optimal Candidates for Induction Chemotherapy in Advanced N-Stage Nasopharyngeal Carcinoma
por: Jiang, Yu-Ting, et al.
Publicado: (2022)

Genome-scale CRISPR-Cas9 knockout screening in nasopharyngeal carcinoma for radiosensitive and radioresistant genes
por: Zhou, Ziyan, et al.
Publicado: (2023)

Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma
por: Peng, Ru-Rong, et al.
Publicado: (2021)

Efficiency of high cumulative cisplatin dose in high‐ and low‐risk patients with locoregionally advanced nasopharyngeal carcinoma
por: Jiang, Yu‐Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1d1bu11b3tte5o4nb8slgr4l1